Natasha Preece

1.5k total citations
7 papers, 162 citations indexed

About

Natasha Preece is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Natasha Preece has authored 7 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Natasha Preece's work include Melanoma and MAPK Pathways (4 papers), Renal cell carcinoma treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). Natasha Preece is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Renal cell carcinoma treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). Natasha Preece collaborates with scholars based in United Kingdom, United States and Belgium. Natasha Preece's co-authors include Caroline J. Springer, Shane Foo, Sophia Frentzas, Jonathan Welti, Andrew R. Reynolds, Thomas Powles, James Larkin, Kevin Sharpe, Stephen J. Mather and Lesley Ogilvie and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Natasha Preece

7 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natasha Preece United Kingdom 6 113 45 36 29 25 7 162
Mark R. Nathan United Kingdom 3 93 0.8× 71 1.6× 36 1.0× 56 1.9× 12 0.5× 5 202
Daniel Winokur United States 3 167 1.5× 90 2.0× 41 1.1× 23 0.8× 20 0.8× 4 193
Golzar Hemmati United States 4 99 0.9× 75 1.7× 27 0.8× 65 2.2× 30 1.2× 9 147
Amy L. Walz United States 8 158 1.4× 64 1.4× 35 1.0× 41 1.4× 14 0.6× 15 268
Edward Grimley United States 10 178 1.6× 56 1.2× 60 1.7× 22 0.8× 10 0.4× 11 249
Valeria Sanabria Guillen United States 8 157 1.4× 83 1.8× 34 0.9× 41 1.4× 26 1.0× 9 255
Desam Roda United Kingdom 5 81 0.7× 66 1.5× 44 1.2× 29 1.0× 16 0.6× 5 152
Eileen Ambing United States 2 95 0.8× 65 1.4× 20 0.6× 77 2.7× 10 0.4× 2 150
Sachie Otsuki Japan 5 143 1.3× 76 1.7× 12 0.3× 28 1.0× 19 0.8× 5 233
Joy Drobnick United Kingdom 4 122 1.1× 47 1.0× 14 0.4× 11 0.4× 19 0.8× 4 176

Countries citing papers authored by Natasha Preece

Since Specialization
Citations

This map shows the geographic impact of Natasha Preece's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Preece with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Preece more than expected).

Fields of papers citing papers by Natasha Preece

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Preece. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Preece. The network helps show where Natasha Preece may publish in the future.

Co-authorship network of co-authors of Natasha Preece

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Preece. A scholar is included among the top collaborators of Natasha Preece based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Preece. Natasha Preece is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Larnyo, Ebenezer, et al.. (2024). Effect of social capital, social support and social network formation on the quality of life of American adults during COVID-19. Scientific Reports. 14(1). 2647–2647. 13 indexed citations
2.
Lopes, Filipa M., María Romina Girotti, Ion Niculescu‐Duvaz, et al.. (2016). Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models. European Journal of Cancer. 61. S199–S199. 5 indexed citations
3.
Saturno, Grazia, Filipa M. Lopes, María Romina Girotti, et al.. (2016). Abstract LB-212: Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models. Cancer Research. 76(14_Supplement). LB–212. 2 indexed citations
4.
Bridgeman, Victoria L., Elaine Y. Wan, Shane Foo, et al.. (2015). Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 15(1). 172–183. 38 indexed citations
5.
Welti, Jonathan, Thomas Powles, Shane Foo, et al.. (2012). Contrasting effects of sunitinib within in vivo models of metastasis. Angiogenesis. 15(4). 623–641. 58 indexed citations
6.
Whittaker, Steven R., Delphine Ménard, Richard Kirk, et al.. (2010). A Novel, Selective, and Efficacious Nanomolar Pyridopyrazinone Inhibitor of V600EBRAF. Cancer Research. 70(20). 8036–8044. 15 indexed citations
7.
Zambon, Alfonso, Delphine Ménard, Bart M. J. M. Suijkerbuijk, et al.. (2010). Novel Hinge Binder Improves Activity and Pharmacokinetic Properties of BRAF Inhibitors. Journal of Medicinal Chemistry. 53(15). 5639–5655. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026